Coronavirus is continuing its spread across the world with more than 58 million confirmed cases in 190 countries and about 1.35 million deaths.
The virus is surging in many regions and countries that had apparent success in suppressing initial outbreaks are also seeing infections rise again.
In the table below, countries can be reordered by deaths, death rate and total cases. In the coloured bars on the right-hand side, countries in which cases have risen to more than 5,000 per day are those with black bars on the relevant date.
Where are cases and deaths rising?
Coronavirus cases have surged over the past few months in several regions of the world and large numbers of new infections are being reported daily.
The most recent figures show more than 580,000 new cases reported in 24 hours.
North America is currently seeing the steepest rise in new cases. The World Health Organization (WHO) has warned that health workers and health systems “are being pushed to the breaking point”.
WHO Director-General Tedros Adhanom Ghebreyesus said more cases of Covid-19 had been reported in the past four weeks than in the first six months of the pandemic.
Second or third rise in cases in some countries
Some countries outside Europe are seeing a second or third rise in cases.
Japan is now on “maximum alert” after seeing a record number of daily cases in a third wave of infections. Prime Minister Yoshihide Suga urged people to do all they could to prevent new infections.
The number of new deaths in Japan, however, has remained relatively low. Other countries that have seen a resurgence of the virus include Turkey, Canada and Russia.
After several weeks without a change, there are now 13 vaccines in phase 3 clinical trials — up two from last week — and six approved for limited use. Still none have been approved for general use, but that could change soon.
Pfizer takes the lead in the vaccine race
Hot off last week’s news that its vaccine is 90% effective, based on early results from a late-stage trial, Pfizer announced on Wednesday that it had finished its trial and its full results show 95% effectiveness. …